Your browser doesn't support javascript.
loading
Teclistamab is an active T cell-redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma.
Pillarisetti, Kodandaram; Powers, Gordon; Luistro, Leopoldo; Babich, Alexander; Baldwin, Eric; Li, Yingzhe; Zhang, Xiaochun; Mendonça, Mark; Majewski, Nate; Nanjunda, Rupesh; Chin, Diana; Packman, Kathryn; Elsayed, Yusri; Attar, Ricardo; Gaudet, François.
Afiliação
  • Pillarisetti K; Oncology and.
  • Powers G; Janssen Biotherapeutics, Janssen Research & Development, LLC, Spring House, PA.
  • Luistro L; Oncology and.
  • Babich A; Oncology and.
  • Baldwin E; IBM Watson Health, New York, NY.
  • Li Y; Legend Biotech, Piscataway, NJ; and.
  • Zhang X; Oncology and.
  • Mendonça M; Century Therapeutics, LLC, Philadelphia, PA.
  • Majewski N; Janssen Biotherapeutics, Janssen Research & Development, LLC, Spring House, PA.
  • Nanjunda R; Janssen Biotherapeutics, Janssen Research & Development, LLC, Spring House, PA.
  • Chin D; Century Therapeutics, LLC, Philadelphia, PA.
  • Packman K; Oncology and.
  • Elsayed Y; Oncology and.
  • Attar R; Oncology and.
  • Gaudet F; Oncology and.
Blood Adv ; 4(18): 4538-4549, 2020 09 22.
Article em En | MEDLINE | ID: mdl-32956453
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article